Show
BioDr. Singh is Associate Professor of Psychiatry and Behavioral Sciences and her multidisciplinary research investigates the neurobiology underlying mood disorders and related psychiatric conditions. Her team uses a clinical translational approach to examine neural circuit dynamics in the human brain in order to ascertain neurobiological correlates of behavior. A major focus of the research is directed to risk factors of mood disorders including genetics as well as developmental exposure and adaptation to early life and family environmental stress. Her team also conducts human clinical trials in developing novel therapies for youth onset mood disorders. The Stanford Pediatric Mood Disorders Research Program promotes healthy brain development across the lifespan through a deeper understanding of how youth adapt to mood symptoms and stress to have successful transitions into adulthood. The program's bold vision is to prevent chronic and progressive mood disorder and to improve the mental health of children, adolescents, young adults, and families through globally recognized research, education, and innovation. The program’s research is multidisciplinary, bringing together experts from the fields of psychiatry, psychology, neuroscience, computer science, biostatistics, genetics, regulatory, and industry to seek answers for complex questions related to brain-behavior-environment relations in developing youth with and at risk for mood disorders, and to accelerate discovery of novel therapeutic strategies. Clinical Focus
Academic AppointmentsAdministrative Appointments
Honors & Awards
Boards, Advisory Committees, Professional Organizations
Professional Education
Community and International Work
ContactAdditional InfoCurrent Research and Scholarly InterestsDr. Singh’s research investigates the developmental psychopathology, pathophysiology, and treatment of pediatric mood disorders, as well as methods to protect and preserve function before and after the onset of depression or mania. Using an integration of clinical, neuroimaging, genetic, and neuroendocrine tools, her research aims to explore the complex risk factors associated with the development of serious mood disorders in children and adolescents. Dr. Singh and her collaborators have also been actively exploring pharmacological and psychotherapeutic methods of treating mood symptoms associated with and leading up to these disorders in youth. Through national collaborations, she is examining the benefits of a combination of family focused psychotherapy with medication in youth offspring of parents with bipolar disorder to reduce mood symptoms and family stress. In addition, she and her group have been conducting studies examining the neuroimaging effects pharmacological and psychosocial interventions – specifically exploring whether such interventions can reduce limbic hyperactivity and increase prefrontal cognitive control. These areas of research aspire to advance understanding of the core mechanisms, endophenotypes, and early interventions for pediatric onset mood disorders. Dr. Singh has been awarded several NIMH awards integrating innovative neuroimaging techniques and mechanisms of emotion regulation to understand the neurodevelopmental basis of mood disorders among children. Dr. Singh has received many honors through the course of her career, including the NARSAD Young Investigator Award, the Klingenstein Third Generation Foundation Depression Fellowship, the American Psychiatric Association’s Young Minds in Psychiatry Award and Blanche F. Ittleson Award for Research in Child/Adolescent Psychiatry, Michigan State University’s Distinguished Young Alumni Award,and the American Academy of Child and Adolescent Psychiatry's Virginia Q. Anthony Outstanding Woman Leader Award. She was also selected as the Akiko Yamazaki and Jerry Yang Faculty Scholar in Pediatric Translational Medicine. Dr. Singh earned her MD at Michigan State University and her MS at University of Michigan. She completed her combined residency in Pediatrics, Psychiatry, and Child and Adolescent Psychiatry at Cincinnati Children’s Hospital Medical Center. After two years of neuroimaging training at the Center for Interdisciplinary Brain Sciences Research at Stanford University, she joined the faculty at Stanford in 2009. Clinical Trials
Projects
2022-23 Courses
Stanford Advisees
Graduate and Fellowship Programs
All Publications
Which of the following could be said of the focus of activity variable in Dr Elder's study?Elder's study? Which of the following could be said of the focus of activity variable in Dr. Elder's study? A proper statistical test would be necessary to determine the effect of the focus of activity variable.
Which of the following could not be said of the focus of activity variable in Dr Elder's study?Which of the following could NOT be said of the focus of activity variable in Dr. Elder's study? The focus of activity finding is not as important as the type of activity finding.
How many participants variables exist in DR elders study?Dr. Elder has four groups of participants (with 30 people in each group).
Which of the following can be said of the interaction in a study quizlet?6. Which of the following CAN be said of the interaction in a study? It can be determined by examining a graph of the results.
|